Stock Analiz

Evommune, Inc. (EVMN) stock forecast and price target

Price $7.63 · data as of November 13, 2026

12-month price target

Average target$21.89
Upside / downside+186.9%
Analysts9
ConsensusBuy
Low $8.00Average $21.89High $28.00

Gold marker: average target · white marker: today’s price ($7.63)

Analyst ratings

Strong buy 4Buy 5Hold 3Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.28+70.7%$625000
Next fiscal year
ends December 31, 2027
$-3.42−4.3%$875000
Next quarter
ends December 31, 2026
$-0.98+31.2%$625000
Quarter after
ends March 31, 2027
$-0.87—$0

Consensus of the analysts covering Evommune, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Evommune stock price target?

The average 12-month target from 9 analysts is $21.89, 186.9% above the current price of $7.63 Targets range from $8.00 to $28.00.

Is Evommune a buy according to analysts?

The consensus rating is “Buy” (4 strong buy, 5 buy, 3 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Evommune expected to earn?

Analysts expect EPS of $-3.28 for the fiscal year ending December 31, 2026 and $-3.42 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.